Kinetic mechanism of human histidine triad nucleotide binding protein 1

Xin Zhou, Tsui Fen Chou, Brandon E. Aubol, Chin Ju Park, Richard Wolfenden, Joseph Adams, Carston R Wagner

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Human histidine triad nucleotide binding protein 1 (hHint1) is a member of a ubiquitous and ancient branch of the histidine triad protein superfamily. hHint1 is a homodimeric protein that catalyzes the hydrolysis of model substrates, phosphoramidate and acyl adenylate, with a high efficiency. Recently, catalytically inactive hHint1 has been identified as the cause of inherited peripheral neuropathy [Zimon, M., et al. (2012) Nat. Genet. 44, 1080-1083]. We have conducted the first detailed kinetic mechanistic studies of hHint1 and have found that the reaction mechanism is consistent with a double-displacement mechanism, in which the active site nucleophile His112 is first adenylylated by the substrate, followed by hydrolysis of the AMP-enzyme intermediate. A transient burst phase followed by a linear phase from the stopped-flow fluorescence assay indicated that enzyme adenylylation was faster than the subsequent intermediate hydrolysis and product release. Solvent viscosity experiments suggested that both chemical transformation and diffusion-sensitive events (product release or protein conformational change) limit the overall turnover. The catalytic trapping experiments and data simulation indicated that the true koff rate of the final product AMP is unlikely to control the overall kcat. Therefore, a protein conformational change associated with product release is likely rate-limiting. In addition, the rate of Hint1 adenylylation was found to be dependent on two residues with pKa values of 6.5 and 8, with the former pKa agreeing well with the nuclear magnetic resonance titration results for the pKa of the active site nucleophile His112. In comparison to the uncatalyzed rates, hHint1 was shown to enhance acyl-AMP and AMP phosphoramidate hydrolysis by 106-108-fold. Taken together, our analysis indicates that hHint1 catalyzes the hydrolysis of phosphoramidate and acyl adenylate with high efficiency, through a mechanism that relies on rapid adenylylation of the active residue, His112, while being partially rate-limited by intermediate hydrolysis and product release associated with a conformational change. Given the high degree of sequence homology of Hint proteins across all kingdoms of life, it is likely that their kinetic and catalytic mechanisms will be similar to those elucidated for hHint1.

Original languageEnglish (US)
Pages (from-to)3588-3600
Number of pages13
JournalBiochemistry
Volume52
Issue number20
DOIs
StatePublished - May 21 2013

Fingerprint

Hydrolysis
Adenosine Monophosphate
Kinetics
Nucleophiles
Catalytic Domain
Proteins
Viverridae
Amino Acid Sequence Homology
Enzyme Assays
Substrates
Enzymes
Titration
Viscosity
human HINT1 protein
Assays
Magnetic Resonance Spectroscopy
Fluorescence
Experiments
Nuclear magnetic resonance
phosphoramidic acid

Cite this

Zhou, X., Chou, T. F., Aubol, B. E., Park, C. J., Wolfenden, R., Adams, J., & Wagner, C. R. (2013). Kinetic mechanism of human histidine triad nucleotide binding protein 1. Biochemistry, 52(20), 3588-3600. https://doi.org/10.1021/bi301616c

Kinetic mechanism of human histidine triad nucleotide binding protein 1. / Zhou, Xin; Chou, Tsui Fen; Aubol, Brandon E.; Park, Chin Ju; Wolfenden, Richard; Adams, Joseph; Wagner, Carston R.

In: Biochemistry, Vol. 52, No. 20, 21.05.2013, p. 3588-3600.

Research output: Contribution to journalArticle

Zhou, X, Chou, TF, Aubol, BE, Park, CJ, Wolfenden, R, Adams, J & Wagner, CR 2013, 'Kinetic mechanism of human histidine triad nucleotide binding protein 1' Biochemistry, vol. 52, no. 20, pp. 3588-3600. https://doi.org/10.1021/bi301616c
Zhou X, Chou TF, Aubol BE, Park CJ, Wolfenden R, Adams J et al. Kinetic mechanism of human histidine triad nucleotide binding protein 1. Biochemistry. 2013 May 21;52(20):3588-3600. https://doi.org/10.1021/bi301616c
Zhou, Xin ; Chou, Tsui Fen ; Aubol, Brandon E. ; Park, Chin Ju ; Wolfenden, Richard ; Adams, Joseph ; Wagner, Carston R. / Kinetic mechanism of human histidine triad nucleotide binding protein 1. In: Biochemistry. 2013 ; Vol. 52, No. 20. pp. 3588-3600.
@article{80824d6979104d87a00d6318a111dd72,
title = "Kinetic mechanism of human histidine triad nucleotide binding protein 1",
abstract = "Human histidine triad nucleotide binding protein 1 (hHint1) is a member of a ubiquitous and ancient branch of the histidine triad protein superfamily. hHint1 is a homodimeric protein that catalyzes the hydrolysis of model substrates, phosphoramidate and acyl adenylate, with a high efficiency. Recently, catalytically inactive hHint1 has been identified as the cause of inherited peripheral neuropathy [Zimon, M., et al. (2012) Nat. Genet. 44, 1080-1083]. We have conducted the first detailed kinetic mechanistic studies of hHint1 and have found that the reaction mechanism is consistent with a double-displacement mechanism, in which the active site nucleophile His112 is first adenylylated by the substrate, followed by hydrolysis of the AMP-enzyme intermediate. A transient burst phase followed by a linear phase from the stopped-flow fluorescence assay indicated that enzyme adenylylation was faster than the subsequent intermediate hydrolysis and product release. Solvent viscosity experiments suggested that both chemical transformation and diffusion-sensitive events (product release or protein conformational change) limit the overall turnover. The catalytic trapping experiments and data simulation indicated that the true koff rate of the final product AMP is unlikely to control the overall kcat. Therefore, a protein conformational change associated with product release is likely rate-limiting. In addition, the rate of Hint1 adenylylation was found to be dependent on two residues with pKa values of 6.5 and 8, with the former pKa agreeing well with the nuclear magnetic resonance titration results for the pKa of the active site nucleophile His112. In comparison to the uncatalyzed rates, hHint1 was shown to enhance acyl-AMP and AMP phosphoramidate hydrolysis by 106-108-fold. Taken together, our analysis indicates that hHint1 catalyzes the hydrolysis of phosphoramidate and acyl adenylate with high efficiency, through a mechanism that relies on rapid adenylylation of the active residue, His112, while being partially rate-limited by intermediate hydrolysis and product release associated with a conformational change. Given the high degree of sequence homology of Hint proteins across all kingdoms of life, it is likely that their kinetic and catalytic mechanisms will be similar to those elucidated for hHint1.",
author = "Xin Zhou and Chou, {Tsui Fen} and Aubol, {Brandon E.} and Park, {Chin Ju} and Richard Wolfenden and Joseph Adams and Wagner, {Carston R}",
year = "2013",
month = "5",
day = "21",
doi = "10.1021/bi301616c",
language = "English (US)",
volume = "52",
pages = "3588--3600",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "20",

}

TY - JOUR

T1 - Kinetic mechanism of human histidine triad nucleotide binding protein 1

AU - Zhou, Xin

AU - Chou, Tsui Fen

AU - Aubol, Brandon E.

AU - Park, Chin Ju

AU - Wolfenden, Richard

AU - Adams, Joseph

AU - Wagner, Carston R

PY - 2013/5/21

Y1 - 2013/5/21

N2 - Human histidine triad nucleotide binding protein 1 (hHint1) is a member of a ubiquitous and ancient branch of the histidine triad protein superfamily. hHint1 is a homodimeric protein that catalyzes the hydrolysis of model substrates, phosphoramidate and acyl adenylate, with a high efficiency. Recently, catalytically inactive hHint1 has been identified as the cause of inherited peripheral neuropathy [Zimon, M., et al. (2012) Nat. Genet. 44, 1080-1083]. We have conducted the first detailed kinetic mechanistic studies of hHint1 and have found that the reaction mechanism is consistent with a double-displacement mechanism, in which the active site nucleophile His112 is first adenylylated by the substrate, followed by hydrolysis of the AMP-enzyme intermediate. A transient burst phase followed by a linear phase from the stopped-flow fluorescence assay indicated that enzyme adenylylation was faster than the subsequent intermediate hydrolysis and product release. Solvent viscosity experiments suggested that both chemical transformation and diffusion-sensitive events (product release or protein conformational change) limit the overall turnover. The catalytic trapping experiments and data simulation indicated that the true koff rate of the final product AMP is unlikely to control the overall kcat. Therefore, a protein conformational change associated with product release is likely rate-limiting. In addition, the rate of Hint1 adenylylation was found to be dependent on two residues with pKa values of 6.5 and 8, with the former pKa agreeing well with the nuclear magnetic resonance titration results for the pKa of the active site nucleophile His112. In comparison to the uncatalyzed rates, hHint1 was shown to enhance acyl-AMP and AMP phosphoramidate hydrolysis by 106-108-fold. Taken together, our analysis indicates that hHint1 catalyzes the hydrolysis of phosphoramidate and acyl adenylate with high efficiency, through a mechanism that relies on rapid adenylylation of the active residue, His112, while being partially rate-limited by intermediate hydrolysis and product release associated with a conformational change. Given the high degree of sequence homology of Hint proteins across all kingdoms of life, it is likely that their kinetic and catalytic mechanisms will be similar to those elucidated for hHint1.

AB - Human histidine triad nucleotide binding protein 1 (hHint1) is a member of a ubiquitous and ancient branch of the histidine triad protein superfamily. hHint1 is a homodimeric protein that catalyzes the hydrolysis of model substrates, phosphoramidate and acyl adenylate, with a high efficiency. Recently, catalytically inactive hHint1 has been identified as the cause of inherited peripheral neuropathy [Zimon, M., et al. (2012) Nat. Genet. 44, 1080-1083]. We have conducted the first detailed kinetic mechanistic studies of hHint1 and have found that the reaction mechanism is consistent with a double-displacement mechanism, in which the active site nucleophile His112 is first adenylylated by the substrate, followed by hydrolysis of the AMP-enzyme intermediate. A transient burst phase followed by a linear phase from the stopped-flow fluorescence assay indicated that enzyme adenylylation was faster than the subsequent intermediate hydrolysis and product release. Solvent viscosity experiments suggested that both chemical transformation and diffusion-sensitive events (product release or protein conformational change) limit the overall turnover. The catalytic trapping experiments and data simulation indicated that the true koff rate of the final product AMP is unlikely to control the overall kcat. Therefore, a protein conformational change associated with product release is likely rate-limiting. In addition, the rate of Hint1 adenylylation was found to be dependent on two residues with pKa values of 6.5 and 8, with the former pKa agreeing well with the nuclear magnetic resonance titration results for the pKa of the active site nucleophile His112. In comparison to the uncatalyzed rates, hHint1 was shown to enhance acyl-AMP and AMP phosphoramidate hydrolysis by 106-108-fold. Taken together, our analysis indicates that hHint1 catalyzes the hydrolysis of phosphoramidate and acyl adenylate with high efficiency, through a mechanism that relies on rapid adenylylation of the active residue, His112, while being partially rate-limited by intermediate hydrolysis and product release associated with a conformational change. Given the high degree of sequence homology of Hint proteins across all kingdoms of life, it is likely that their kinetic and catalytic mechanisms will be similar to those elucidated for hHint1.

UR - http://www.scopus.com/inward/record.url?scp=84878238605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878238605&partnerID=8YFLogxK

U2 - 10.1021/bi301616c

DO - 10.1021/bi301616c

M3 - Article

VL - 52

SP - 3588

EP - 3600

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 20

ER -